Advertisement

Caffeine Citrate Injection and Oral Solution

[22 July 2014]

Products Affected - Description

Caffeine citrate injection
Caffeine citrate injection, American Regent
20 mg/mL, 3 mL vial (NDC 00517-0020-10)
 
Cafcit injection, Bedford
20 mg/mL, 3 mL vial (NDC 55390-0357-03) - discontinued

 
Caffeine citrate injection, Fresenius Kabi
20 mg/mL, 3 mL vial (NDC 63323-0407-03)
 
Caffeine citrate injection, Paddock
20 mg/mL, 3 mL vial (NDC 00574-0823-01) - discontinued
 
Caffeine citrate injection, Sagent
20 mg/mL, 3 mL vial (NDC 25021-0601-03)
 
Cafcit injection, West-Ward
20 mg/mL, 3 mL vial (NDC 55390-0357-03)


Caffeine citrate oral solution
Cafcit oral solution, Bedford
20 mg/mL oral solution, 3 mL vial (NDC 55390-0358-03) - discontinued

Caffeine citrate oral solution, Paddock
20 mg/mL oral solution, 3 mL vial (NDC 00574-0152-10) - discontinued

Reason for the Shortage

  • American Regent had temporarily suspended manufacture of most drug products in April, 2011.
  • American Regent resumed manufacturing in Shirley, New York in early-May, 2011.
  • Paddock discontinued caffeine citrate injection and oral solution in May 2014.
  • Sagent states the reason for the shortage is increased demand.
  • West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired Cafcit injection from Bedford in July 2014. West-Ward will actively market Cafcit injection.

Available Products

Caffeine citrate injection
Caffeine citrate injection, Caraco
20 mg/mL, 3 mL vial (NDC 47335-0289-40)

Caffeine citrate oral solution

Caffeine citrate oral solution, Fresenius Kabi
20 mg/mL oral solution, 3 mL vial (NDC 63323-0406-03)
 
Caffeine citrate oral solution, Caraco
20 mg/mL oral solution, 3 mL vial (NDC 47335-0290-44)
 
Caffeine citrate oral solution, Sagent
20 mg/mL, 3 mL vial (NDC 25021-0602-03)

Estimated Resupply Dates

Caffeine citrate injection
  • American Regent has caffeine citrate 20 mg/mL 3 mL vials for injection on back order and the company cannot estimate a release date.
  • Fresenius Kabi has caffeine citrate 3 mL vials on back order and the company estimates a release date in mid-August 2014.
  • Sagent has caffeine citrate 3 mL vials on back order and the company estimates a release date in August 2014.
  • West-Ward estimates Cafcit injection will be available for ordering and shipping starting in late-July 2014.

Caffeine citrate oral solution

  • All presentations are currently available.

Related Shortages

Updated

July 22, 2014; June 30, 2014; May 15, 2014; May 14, 2014; May 5, 2014; April 21, 2014; April 3, 2014; February 27, 2014; February 3, 2014; December 13, 2013; November 4, 2013; September 12, 2013; August 28, 2013; August 22, 2013; July 18, 2013; June 27, 2013; May 20, 2013; May 15, 2013; March 7, 2013; December 19, 2012; October 18, 2012; September 24, 2012; July 12, 2012; May 25, 2012; April 17, 2012; March 20, 2012; March 9, 2012; February 7, 2012; January 3, 2012; December 21, 2011; November 30, 2011; November 21, 2011; November 11, 2011, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement